| Product Code: ETC8454510 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Myanmar Irritable Bowel Syndrome (IBS) Market Overview |
3.1 Myanmar Country Macro Economic Indicators |
3.2 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, 2021 & 2031F |
3.3 Myanmar Irritable Bowel Syndrome (IBS) Market - Industry Life Cycle |
3.4 Myanmar Irritable Bowel Syndrome (IBS) Market - Porter's Five Forces |
3.5 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F |
3.7 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Myanmar Irritable Bowel Syndrome (IBS) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of irritable bowel syndrome in Myanmar |
4.2.2 Growing healthcare infrastructure and access to medical facilities |
4.2.3 Adoption of Western dietary habits leading to a rise in digestive disorders in the population |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for diagnosing and treating irritable bowel syndrome |
4.3.2 High cost of medications and treatments for irritable bowel syndrome in Myanmar |
4.3.3 Cultural stigma and lack of awareness leading to underreporting and undertreatment of the condition |
5 Myanmar Irritable Bowel Syndrome (IBS) Market Trends |
6 Myanmar Irritable Bowel Syndrome (IBS) Market, By Types |
6.1 Myanmar Irritable Bowel Syndrome (IBS) Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Lubiprostone, 2021- 2031F |
6.1.4 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Linaclotide, 2021- 2031F |
6.1.5 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Eluxadoline, 2021- 2031F |
6.1.6 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Rifaximin, 2021- 2031F |
6.1.7 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Alosetron, 2021- 2031F |
6.1.8 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Myanmar Irritable Bowel Syndrome (IBS) Market, By Medical Condition |
6.2.1 Overview and Analysis |
6.2.2 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-Constipation, 2021- 2031F |
6.2.3 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-diarrhea, 2021- 2031F |
6.2.4 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Mixed, 2021- 2031F |
6.3 Myanmar Irritable Bowel Syndrome (IBS) Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.4 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4 Myanmar Irritable Bowel Syndrome (IBS) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Myanmar Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
7 Myanmar Irritable Bowel Syndrome (IBS) Market Import-Export Trade Statistics |
7.1 Myanmar Irritable Bowel Syndrome (IBS) Market Export to Major Countries |
7.2 Myanmar Irritable Bowel Syndrome (IBS) Market Imports from Major Countries |
8 Myanmar Irritable Bowel Syndrome (IBS) Market Key Performance Indicators |
8.1 Number of healthcare facilities offering irritable bowel syndrome diagnosis and treatment services in Myanmar |
8.2 Percentage increase in the number of diagnosed irritable bowel syndrome cases year-on-year |
8.3 Patient satisfaction levels with the quality of care and treatment received for irritable bowel syndrome |
9 Myanmar Irritable Bowel Syndrome (IBS) Market - Opportunity Assessment |
9.1 Myanmar Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Myanmar Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Medical Condition, 2021 & 2031F |
9.3 Myanmar Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Myanmar Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Myanmar Irritable Bowel Syndrome (IBS) Market - Competitive Landscape |
10.1 Myanmar Irritable Bowel Syndrome (IBS) Market Revenue Share, By Companies, 2024 |
10.2 Myanmar Irritable Bowel Syndrome (IBS) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here